RecruitingNot applicableNCT05190172

PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas

Studying Oligodendroglioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oslo University Hospital
Principal Investigator
Petter Brandal, MD PhD
Head of Neurooncology
Intervention
Radiation therapy(radiation)
Enrollment
225 enrolled
Eligibility
18-65 years · All sexes
Timeline
2022 – 2043

Study locations (1)

Collaborators

Sahlgrenska University Hospital · The Skandion Clinic · University Hospital of North Norway · St. Olavs Hospital · Haukeland University Hospital · Lund University Hospital · Ôrebro University Hospital · Uppsala University Hospital · Karolinska University Hospital · University Hospital, Umeå · University Hospital, Linkoeping · Jönköping University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05190172 on ClinicalTrials.gov

Other trials for Oligodendroglioma

Additional recruiting or active studies for the same condition.

See all trials for Oligodendroglioma →

← Back to all trials